HOME >> MEDICINE >> NEWS
First US SARS vaccine trial opens at NIH

Powerful research tools that speed up vaccine development have led to the start today of human tests for a preventive vaccine against the respiratory disease SARS. The disease killed hundreds of people around the world before it was brought under control in 2003 with aggressive conventional public health measures.

Researchers at the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), will conduct the trials. The experimental vaccine against SARS, or severe acute respiratory syndrome, will be tested on 10 healthy volunteers at the NIH Clinical Center in Bethesda, MD. The clinic will do periodic follow-up exams on each volunteer for 32 weeks.

"This experimental vaccine is an outstanding achievement by NIAID researchers," said Health and Human Services Secretary Tommy G. Thompson. "It is a model for research that could greatly shorten the time needed to create vaccines to be tested against other diseases."

"The Vaccine Research Center, a cutting-edge facility established here at NIH just five years ago, encompasses the entire spectrum of vaccine development from basic research to clinical testing," says NIH Director Elias A. Zerhouni, M.D. "This is why our team at NIAID has been able to develop this vaccine at an unprecedented pace, using technological discoveries that were not available just a few short years ago."

The primary goal of the study is to determine if the experimental vaccine is safe in people. A secondary goal is to assess how well the vaccine stimulates the immune system to produce antibodies and cellular immunity, in this case, focusing on the SARS spike protein. The spike protein protrudes from the virus' outer envelope and helps it bind to cells it infects.

SARS was spotted first in China in November 2002. The virus sickened 8,096 and killed 774 worldwide by July 2003, according to the World Health Organization (WHO). SARS was
'"/>

Contact: Linda Joy
ljoy@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
13-Dec-2004


Page: 1 2 3

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. First UK cases of previously rare disease reported in gay men
3. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
4. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
5. First US kidney cancer vaccine trial underway at Columbia
6. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
7. First blood test to diagnose paralyzing, blinding disease
8. First-ever safety study of medical cannabis use in Canada launched
9. First solid evidence that the study of music promotes intellectual development
10. First medical test on CD gets good results
11. First proof that cutting Rx drugs due to cost harms health

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/2/2018)... ... September 02, 2018 , ... Eaton Hotel in ... The hotel itself, which opened this week, inspires creativity and innovation among its ... , Eaton Hotel DC currently features 209 hotel rooms, a wellness center, a ...
(Date:9/1/2018)... ... ... SignatureCare Emergency Center is looking to award their 2018 Fall Scholarship. The ... Get your applications in now as the deadline is approaching fast. (July 31) , ... medical student at Texas Southern University. Wu was inspired to go into the medical ...
(Date:9/1/2018)... AUSTIN, Texas (PRWEB) , ... September 01, 2018 ... ... health event proclaimed by the International Veterinary Academy of Pain Management (IVAPM) that ... Texas Veterinary Medical Association (TVMA) is partnering with IVAPM by educating pet owners ...
(Date:8/31/2018)... Mich. (PRWEB) , ... August 31, 2018 , ... ... provider, will host an Open House on Wednesday, September 12 from 1:00-3:00 pm. ... available in Grand Rapids, as well as tour the facility, meet our staff ...
(Date:8/31/2018)... ... August 31, 2018 , ... The social impact documentary ... CSUN Psychology Professor and NIH-funded researcher Luciana Lagana, aka Dr. Luciana, has ... the Action on Film International Film Festival, IndieFEST Film Awards, Shawna Shea Memorial Film ...
Breaking Medicine News(10 mins):
(Date:9/12/2018)... ... September 13, 2018 , ... ... Webinar**, Sept. 27, 2018 — 1:30 p.m. – 3:00 p.m. ET, http://info.fdanews.com/safety-reporting-in-global-clinical-trials ... reporting by as much as fifty percent. , This can be due ...
(Date:9/7/2018)... ... September 06, 2018 , ... This year, the California ... Award for his presentation of: IDEAL IMPLANT® - Seven-Year Clinical Trial Results at the ... paper again at the upcoming ASPS (American Society of Plastic Surgeons) meeting in Chicago ...
(Date:9/7/2018)... ... September 07, 2018 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... Name of the Creator and says the proof is undeniable. , Yisrayl scolds mainstream religions ... of the Creator’s Name. Yisrayl shows there is great meaning in the Name, and to ...
Breaking Medicine Technology:
Cached News: